| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2023-05-05 | LEIDEN JEFFREY M | Executive Chairman | Sell | 708 | $349.38 | $247,361.04 | -1.9% | → |
| 2023-05-03 | LEIDEN JEFFREY M | Executive Chairman | Sell | 10,958 | $349.98 | $3,835,061.76 | -4.3% | → |
| 2023-05-03 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 4,403 | $350.71 | $1,544,186.50 | -2.3% | → |
| 2023-05-02 | Bhatia Sangeeta N. | Director | Sell | 580 | $348.28 | $202,003.80 | -2.3% | → |
| 2023-04-27 | Kewalramani Reshma | CEO & President | Sell | 3,317 | $339.08 | $1,124,726.05 | -0.9% | → |
| 2023-04-12 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 7,567 | $326.70 | $2,472,164.15 | -5.6% | → |
| 2023-04-12 | SACHS BRUCE I | Director | Sale+OE | 21,300 | $326.73 | $6,959,421.75 | -12.4% | → |
| 2023-04-04 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 522 | $315.81 | $164,854.34 | -0.2% | → |
| 2023-03-24 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 1,768 | $305.38 | $539,911.84 | -3.4% | → |
| 2023-03-17 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 2,000 | $296.39 | $592,786.00 | -0.6% | → |
| 2023-03-16 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 2,746 | $300.59 | $825,422.76 | -2.7% | → |
| 2023-03-13 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3,749 | $292.97 | $1,098,333.45 | -0.7% | → |